← Case library
OMFS-0134OncologyadvancedHard palate and gingiva

Purple palatal lesions in an HIV-positive patient

38-year-old male

Draft — educational study aid, pending faculty review.

§Chief complaint

Purple patches on the palate that are enlarging

§Medical & dental history

  • 01HIV positive, poor antiretroviral adherence, CD4 count 92 cells/uL
  • 02Recurrent oral candidiasis
  • 03Irregular attendance; generalised periodontitis

§Clinical examination

  • 01Multiple violaceous macules and nodules on the hard palate and maxillary gingiva
  • 02Some lesions ulcerated with contact bleeding
  • 03Concomitant pseudomembranous candidiasis
  • 04Generalised lymphadenopathy

§ figuresFigures (2)

Fig. 1This HIV-positive patient presented with an intraoral Kaposi’s sarcoma lesion with an overlying candidiasis infection. This AIDS patient exhibited a CD4+ T-cell count <200, and a high viral load. Initially, the KS les

Kaposi’s sarcoma intraoral AIDS 072 lores” · Photo Credit: Sol Silverman, Jr., D.D.S. Content Providers: CDC/ Sol Silverman, · Public domain · Wikimedia Commons

Fig. 2This HIV patient presented with labial and gingival Kaposi’s sarcoma secondary to his AIDS infection which included the maxilla. In approximately 7.5-10 percent of AIDS patients display signs of oral Kaposi’s sarcoma, an

KaposisSarcomaFromCDC03-18-06” · Photo Credit: Sol Silverman, Jr., D.D.S. Content Providers: CDC/ Sol Silverman, · Public domain · Wikimedia Commons

Verified open-access images only, reproduced for education under their stated licences · no AI-generated or illustrative artwork · Kaposi Sarcoma figures pending faculty review.

§Differential diagnosis

Kaposi sarcomaViolaceous multifocal lesions, HHV-8, immunosuppression
Bacillary angiomatosisBartonella, responds to antibiotics
Oral melanomaBrown-black rather than violaceous, usually solitary
Pyogenic granulomaSolitary, bright red, gingival, trauma-related

§Final diagnosis

AIDS-associated (epidemic) Kaposi sarcoma of the oral cavity

Multifocal violaceous lesions in a profoundly immunosuppressed patient are Kaposi sarcoma until biopsy proves otherwise; HHV-8 (LANA-1) immunostaining confirms it and separates it from vascular mimics.

§Investigations

  • 01Incisional biopsy with HHV-8 LANA-1 immunohistochemistry
  • 02CD4 count and HIV viral load
  • 03Staging for visceral and cutaneous involvement
  • 04Screening for other opportunistic infections

§Treatment plan

  • 01Optimise antiretroviral therapy — the single most effective intervention
  • 02Local therapy: intralesional vinblastine or radiotherapy for symptomatic oral lesions
  • 03Systemic chemotherapy for widespread or visceral disease
  • 04Treat candidiasis and provide periodontal care

§Histopathology report

Proliferation of spindle cells forming slit-like vascular spaces with extravasated erythrocytes and haemosiderin, plasma cell infiltrate. HHV-8 LANA-1 positive. Kaposi sarcoma.

§Follow-up & outcome

  • 01Marked regression of oral lesions after 6 months of effective antiretroviral therapy
  • 02CD4 rose to 310 cells/uL
  • 03Residual lesions treated with intralesional vinblastine

§Clinical pearls / learning points

  • 01Oral Kaposi sarcoma may be the first presentation of undiagnosed HIV — offer testing.
  • 02Immune reconstitution alone often produces substantial regression.
  • 03Palatal and gingival sites are the most frequent oral locations.

§References

  • WHO Classification of Head and Neck Tumours, 5th ed. (2022).

§Similar cases

41 cases in the library